Acarix A/S -SEK0.04 -10.32% Today
1D 1W 1M 3M 1Y 5Y
7 Nov Expected
This list is based on the watchlists of people on Stock Events who follow ACARIX.ST. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Masimo Corporation specializes in noninvasive monitoring technologies, a direct competitor in the medical device market focusing on advanced patient monitoring. Edwards Lifesciences
EW
Mkt Cap 42.14B
Edwards Lifesciences Corporation is known for its heart valve therapy products and critical care technologies, competing in the cardiovascular market. Boston Scientific
BSX
Mkt Cap 120.45B
Boston Scientific Corporation offers a wide range of medical devices including those for cardiovascular health, directly competing with Acarix AB's offerings. Medtronic
MDT
Mkt Cap 113.61B
Medtronic plc manufactures and sells device-based medical therapies, including those for cardiac and vascular diseases, competing in the same space as Acarix AB. Intuitive Surgical
ISRG
Mkt Cap 175.06B
Intuitive Surgical, Inc. provides robotic-assisted surgical technologies, indirectly competing by offering advanced medical devices in the same healthcare sectors.
Stryker Corporation specializes in a variety of medical technologies, including those for surgical and cardiac applications, making it a competitor in the medical device field. Zimmer Biomet
ZBH
Mkt Cap 23.51B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its innovations in medical devices place it in indirect competition with Acarix AB. Johnson & Johnson
JNJ
Mkt Cap 399.26B
Johnson & Johnson engages in the production of healthcare products, including medical devices, competing broadly in the healthcare market. Koninklijke Philips N.V.
PHG
Mkt Cap 28.48B
Koninklijke Philips N.V. offers various health technology products and services, including those for cardiac care, competing in the same industry as Acarix AB.
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Show more...